Superinfection with SARS-CoV-2 Has Deleterious Effects on Mycobacterium bovis BCG Immunity and Promotes Dissemination of Mycobacterium tuberculosis
Authors:
Open Access
- 26 October 2022
- journal article
- research article
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 10 (5) , e0307522
Abstract
Prior to SARS-CoV-2,M. tuberculosiswas the leading infectious disease killer, with an estimated one-third of the world’s population infected and 1.7 million deaths a year. Here, we show that SARS-CoV-2 superinfection caused increased bacterial dissemination inM. tuberculosis-infected mice along with immune and pathological changes.Keywords
Funding Information
- U.S. Department of Agriculture (2019-05849)
- U.S. Department of Agriculture (2018-67015-28243)
- United States Agency for International Development (20000010565)
This publication has 52 references indexed in Scilit:
- The immunological life cycle of tuberculosisNature Reviews Immunology, 2012
- ‘Coinfection-helminthes and tuberculosis’Current Opinion in HIV and AIDS, 2012
- Differentiation and Recruitment of Th9 Cells Stimulated by Pleural Mesothelial Cells in Human Mycobacterium tuberculosis InfectionPLOS ONE, 2012
- The Relationship between Tuberculosis and Influenza Death during the Influenza (H1N1) Pandemic from 1918-19Computational and Mathematical Methods in Medicine, 2012
- Membrane-Bound IL-22 after De Novo Production in Tuberculosis and Anti-Mycobacterium tuberculosis Effector Function of IL-22+ CD4+ T CellsThe Journal of Immunology, 2011
- HIV-1/Mycobacterium tuberculosisCoinfection Immunology: How Does HIV-1 Exacerbate Tuberculosis?Infection and Immunity, 2011
- Pathological role of interleukin 17 in mice subjected to repeated BCG vaccination after infection with Mycobacterium tuberculosisJournal of Experimental Medicine, 2010
- Understanding Latent Tuberculosis: A Moving TargetThe Journal of Immunology, 2010
- Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectivenessThe Lancet, 2006
- Immunological and pathological comparative analysis between experimental latent tuberculous infection and progressive pulmonary tuberculosisClinical and Experimental Immunology, 2002